Related Experiment Videos
[NSAID-induced ulcer and its complications]
1Mag-tarmcentrum, Ersta sjukhus, Stockholm.
Nordisk Medicin
|June 1, 1997
Summary
Non-steroidal anti-inflammatory drugs (NSAIDs) increase ulcer risk, especially in older adults or those with prior complications. Prophylaxis with omeprazole or misoprostol is recommended for high-risk NSAID users.
Area of Science:
- Gastroenterology
- Pharmacology
- Internal Medicine
Background:
- Non-steroidal anti-inflammatory drugs (NSAIDs) consumption has risen significantly.
- NSAIDs are linked to serious gastrointestinal side effects, including ulcers and complications.
- Annual hospitalizations for NSAID-induced ulcers affect 1-2% of users, with a 10% mortality rate.
Purpose of the Study:
- To review the risks and management of NSAID-induced gastrointestinal complications.
- To evaluate the efficacy of different prophylactic agents against NSAID-induced ulcers.
- To discuss the potential of novel NSAIDs with improved gastrointestinal safety profiles.
Main Methods:
- Literature review of NSAID-related gastrointestinal side effects and their management.
- Analysis of risk factors associated with NSAID-induced ulcers.
- Comparison of the efficacy of histamine H2-antagonists, omeprazole, and misoprostol for ulcer prevention.
- Consideration of cyclo-oxygenase 2 (COX-2) selective NSAIDs.
Main Results:
- Advanced age, history of peptic ulcer, high-dose NSAID use, and cardiovascular disease are key risk factors.
- Helicobacter pylori infection does not appear to worsen NSAID-induced ulcers.
- Omeprazole is effective for both gastric and duodenal ulcers; misoprostol reduces serious complications by 40%.
Conclusions:
- Prophylaxis is crucial for high-risk patients due to asymptomatic ulcer complications.
- Omeprazole and misoprostol offer significant gastrointestinal protection against NSAID-induced ulcers.
- COX-2 selective NSAIDs may provide anti-inflammatory benefits with reduced gastrointestinal risk.